Enthera Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$42.6M
- Investors
-
10
Enthera General Information
Description
Developer of biotherapeutics designed to treat autoimmune disorders. The company's pipelined products target pathways involved in cell apoptosis in the gut, pancreas, and other organs which plays a key role in the development of type 1 diabetes and inflammatory bowel disease, enabling the medical community to effectively combat intractable autoimmune diseases.
Contact Information
Website
www.entherapharmaceuticals.comCorporate Office
- Via Visconti di Modrone, 18
- 20122 Milan(Lombardy)
- Italy
Corporate Office
- Via Visconti di Modrone, 18
- 20122 Milan(Lombardy)
- Italy
Enthera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 28-Jan-2021 | $42.6M | Completed | Clinical Trials - Phase 1 | ||
| 3. Seed Round | 24-Jul-2018 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 10-May-2018 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 01-Oct-2016 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Enthera Comparisons
Industry
Financing
Details
Enthera Competitors (26)
One of Enthera’s 26 competitors is Cognition Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cognition Therapeutics | Formerly VC-backed | New York, NY | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Equillium | Formerly VC-backed | La Jolla, CA | ||||
| Mighty Therapeutics | Private Equity-Backed | Needham, MA | ||||
| Abliva | Formerly VC-backed | Lund, Sweden |
Enthera Patents
Enthera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025252702-A1 | Tmem219 antibodies for medical use | Pending | 11-Apr-2024 | ||
| EP-4631572-A1 | Tmem219 antibodies for medical use | Inactive | 11-Apr-2024 | ||
| WO-2025215235-A1 | Tmem219 antibodies for medical use | Pending | 11-Apr-2024 | ||
| EP-4537907-A1 | Cd248 inhibitors and uses thereof | Inactive | 10-Oct-2023 | ||
| EP-4791507-A1 | Cd248 inhibitors and uses thereof | Pending | 10-Oct-2023 | C07K16/2851 |
Enthera Signals
Enthera Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| Banca Profilo | Asset Manager | Minority | ||
| Banor Sim | Family Office | Minority | ||
| Landmark Capital (Italy) | Family Office | Minority | ||
| Roche Venture Fund | Corporate Venture Capital | Minority |
Enthera FAQs
-
When was Enthera founded?
Enthera was founded in 2016.
-
Where is Enthera headquartered?
Enthera is headquartered in Milan, Italy.
-
What is the size of Enthera?
Enthera has 15 total employees.
-
What industry is Enthera in?
Enthera’s primary industry is Drug Discovery.
-
Is Enthera a private or public company?
Enthera is a Private company.
-
What is Enthera’s current revenue?
The current revenue for Enthera is .
-
How much funding has Enthera raised over time?
Enthera has raised $47.2M.
-
Who are Enthera’s investors?
AbbVie Ventures, Banca Profilo, Banor Sim, Landmark Capital (Italy), and Roche Venture Fund are 5 of 10 investors who have invested in Enthera.
-
Who are Enthera’s competitors?
Cognition Therapeutics, AnTolRx, Equillium, Mighty Therapeutics, and Abliva are some of the 26 competitors of Enthera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process